Evidence map›Paper›PMID 30803976›Full record

ArticleAntimicrobial agents and chemotherapy2019

Whole-Genome Sequencing Analysis of Multidrug-Resistant Serotype 15A Streptococcus pneumoniae in Japan and the Emergence of a Highly Resistant Serotype 15A-ST9084 Clone.

Satoshi Nakano, Takao Fujisawa, Yutaka Ito, Bin Chang, Yasufumi Matsumura, Masaki Yamamoto, Shigeru Suga, Makoto Ohnishi, Miki Nagao

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Serotype distribution and antimicrobial resistance ofJournal of medical microbiology · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Serotypes and Antibiotic Resistance ofPathogens (Basel, Switzerland) · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Genomic Characterization of Multidrug-ResistantFrontiers in microbiology · 2020
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Satoshi NakanoKyoto University Graduate School of Medicine, Kyoto, Japan snakano@kuhp.kyoto-u.ac.jp.
Takao FujisawaNational Hospital Organization Mie National Hospital, Tsu, Japan.
Yutaka ItoNagoya City University Graduate School of Medical Science, Nagoya, Japan.ORCID 0000-0002-1538-5551
Bin ChangNational Institute of Infectious Diseases, Tokyo, Japan.
Yasufumi MatsumuraKyoto University Graduate School of Medicine, Kyoto, Japan.ORCID 0000-0001-8595-8944
Masaki YamamotoKyoto University Graduate School of Medicine, Kyoto, Japan.
Shigeru SugaNational Hospital Organization Mie National Hospital, Tsu, Japan.
Makoto OhnishiNational Institute of Infectious Diseases, Tokyo, Japan.
Miki NagaoKyoto University Graduate School of Medicine, Kyoto, Japan.
Kyoto University · JPNational Institute of Infectious Diseases · JPNational Mie Hospital · JPNagoya City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the introduction of pneumococcal conjugate vaccines (PCVs), an increase in the incidence of disease attributable to serotype 15A-ST63 (sequence type 63) pneumococci has been observed in many regions worldwide. We conducted a nationwide pediatric pneumococcal infection surveillance study between 2012 and 2014 in Japan. In the surveillance study, we detected multidrug-resistant serotype 15A-CC63 (clonal complex 63) strains (resistant to macrolides, penicillin, cefotaxime, and meropenem); in this study, we analyzed these resistant isolates to determine the dynamics and mechanism of resistance using whole-genome sequencing. In most of the penicillin-, cefotaxime-, and meropenem-resistant strains, recombination occurred in the

Indexed as

Anti-Bacterial AgentsCefotaximeDrug Resistance, Multiple, BacterialJapanMeropenemMicrobial Sensitivity TestsPenicillinsSerogroupSerotypingStreptococcus pneumoniaeWhole Genome SequencingAnti-Bacterial AgentsCefotaximeMeropenemPenicillins15AcefotaximeJapanmultidrug resistancePCV13PCV7serotype shiftST63ST9084Streptococcus pneumoniae

Identifiers

PMID30803976
PMCPMC6496056
OpenAlexW2916796177

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.